Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.

In both control and tremor mice, administration of DPCPX reduced the amplitude threshold at which DBS produced involuntary movements, thereby demonstrating the capacity of adenosine to extend the ...

Dipyridamole inhibits the uptake of adenosine into platelets, endothelial cells and erythrocytes in vitro and in vivo. This inhibition results in an increase in local concentrations of adenosine ...